Trial Profile
An Open Label, Single Dose, Single Period Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] APD421 Administered Via the Intravenous Route to Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2019
Price :
$35
*
At a glance
- Drugs Amisulpride (Primary)
- Indications Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
- Focus Pharmacokinetics
- Sponsors Acacia Pharma
- 09 Sep 2016 New trial record